牛叉诊股

[{"date":"2026.07.03","stock":"5.37","trade":"1.88","ind":"0.64"},{"date":"2026.07.02","stock":"3.47","trade":"-0.24","ind":"-3.85"},{"date":"2026.07.01","stock":"7.31","trade":"4.33","ind":"-0.53"},{"date":"2026.06.30","stock":"-1.05","trade":"-0.54","ind":"2.48"},{"date":"2026.06.29","stock":"0.91","trade":"7.43","ind":"0.19"},{"date":"2026.06.26","stock":"-5.06","trade":"-3.87","ind":"-3.44"},{"date":"2026.06.25","stock":"-1.57","trade":"-1.00","ind":"1.82"},{"date":"2026.06.24","stock":"-2.20","trade":"-1.03","ind":"1.24"},{"date":"2026.06.23","stock":"-4.95","trade":"2.96","ind":"-3.17"},{"date":"2026.06.22","stock":"-2.53","trade":"-0.76","ind":"2.13"},{"date":"2026.06.18","stock":"9.99","trade":"1.76","ind":"0.94"},{"date":"2026.06.17","stock":"-1.11","trade":"-0.52","ind":"1.31"},{"date":"2026.06.16","stock":"-2.52","trade":"-0.68","ind":"0.93"},{"date":"2026.06.15","stock":"0.33","trade":"-0.31","ind":"3.79"},{"date":"2026.06.12","stock":"3.40","trade":"2.41","ind":"0.75"},{"date":"2026.06.11","stock":"2.37","trade":"-1.14","ind":"-0.68"},{"date":"2026.06.10","stock":"-9.99","trade":"-0.10","ind":"-2.06"},{"date":"2026.06.09","stock":"1.82","trade":"0.25","ind":"3.02"},{"date":"2026.06.08","stock":"-3.51","trade":"-2.98","ind":"-3.22"},{"date":"2026.06.05","stock":"-1.66","trade":"0.27","ind":"-2.21"},{"date":"2026.06.04","stock":"7.17","trade":"-1.92","ind":"-0.27"}]

万泽股份,深证成指,生物制品指数

压力支撑

该股压力位为31.46元，支撑位为29.86元。

[{"text":"\u538b\u529b\u4f4d","value":"31.46","date":1783008000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"29.86","date":1783008000,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.4资金面打败了47%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金流入较多，投资者可加强关注该行业的个股。

更新时间：07月03日 20:30

机构今日流向(万元)	1123.49	机构5日流向(万元)	5912.96
机构10日流向(万元)	1687.36	机构20日流向(万元)	-1971.84

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量增加4962.50万股，其中基金净减仓10家，主力净增仓90家，请投资者中长期谨慎为宜。

截止2025-12-31，共235家主力机构（基金226家，一般法人7家，社保基金2家），持仓量总计30084.27万股，占流通A股60.17%
其中，基金持仓与2025-06-30相比：
增仓：17家，增持 420.19万股
减仓：27家，减持 1299.27万股
新出现在主力名单中：184家，持有12733.13万股
从主力名单中消失：94家，原持有7410.62万股

消息面诊股

诊断结果：5.4消息面打败了4%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	年度股东大会	2026-06-06
一般消息	重大事项	公司股东股份解押	2026-06-06
一般消息	重大事项	公司股东股份解押	2026-05-30
利空	重大事项	公司违规：处罚类型	2026-04-30
一般消息	分红转增	不分配不转增	2026-04-21
一般消息	重大事项	关联交易	2026-04-21
一般消息	重大事项	公司股东股份解押	2026-04-04
一般消息	募资投向	公司出售资产	2026-03-27
一般消息	重大事项	公司股东股份解押	2026-01-21
一般消息	高管变动	不再担任	2025-12-08
一般消息	高管变动	取消监事会	2025-10-29
一般消息	分红转增	不分配不转增	2025-08-23

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	0条	1条

行业面诊股

诊断结果：8.2行业面打败了97%的股票生物制品行业最新资金流向

近10日来该行业走势明显向上，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，明显跑赢大盘。

[{"date":"2026.07.03","price":"0.64","value":"1.88"},{"date":"2026.07.02","price":"-3.85","value":"-0.24"},{"date":"2026.07.01","price":"-0.53","value":"4.33"},{"date":"2026.06.30","price":"2.48","value":"-0.54"},{"date":"2026.06.29","price":"0.19","value":"7.43"},{"date":"2026.06.26","price":"-3.44","value":"-3.87"},{"date":"2026.06.25","price":"1.82","value":"-1.00"},{"date":"2026.06.24","price":"1.24","value":"-1.03"},{"date":"2026.06.23","price":"-3.17","value":"2.96"},{"date":"2026.06.22","price":"2.13","value":"-0.76"},{"date":"2026.06.18","price":"0.94","value":"1.76"},{"date":"2026.06.17","price":"1.31","value":"-0.52"},{"date":"2026.06.16","price":"0.93","value":"-0.68"},{"date":"2026.06.15","price":"3.79","value":"-0.31"},{"date":"2026.06.12","price":"0.75","value":"2.41"},{"date":"2026.06.11","price":"-0.68","value":"-1.14"},{"date":"2026.06.10","price":"-2.06","value":"-0.10"},{"date":"2026.06.09","price":"3.02","value":"0.25"},{"date":"2026.06.08","price":"-3.22","value":"-2.98"},{"date":"2026.06.05","price":"-2.21","value":"0.27"},{"date":"2026.06.04","price":"-0.27","value":"-1.92"}]

深证成指,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	三生国健	55.89%	46.45%	5.8分
2	荣昌生物	40.36%	31.34%	6.3分
3	诺唯赞	39.55%	20.52%	6.2分
4	欧林生物	38.70%	11.60%	5.7分
5	诺诚健华	38.44%	19.29%	6.2分
6	赛伦生物	33.07%	11.55%	4.7分
7	百普赛斯	32.89%	11.83%	5.5分
8	昊帆生物	23.39%	18.93%	6.6分
9	君实生物	22.55%	28.00%	5.7分
10	迈威生物	19.05%	24.17%	5.4分
11	义翘神州	14.68%	14.92%	5.3分
12	科兴制药	13.81%	22.26%	5.6分
13	甘李药业	13.55%	13.43%	6.0分
14	赛升药业	12.67%	17.04%	5.0分
15	沃森生物	11.86%	13.11%	6.5分
16	双成药业	11.09%	23.43%	6.1分
17	-	10.23%	8.10%	分
18	禾元生物	9.79%	22.49%	6.2分
19	我武生物	9.73%	13.33%	5.4分
20	智翔金泰	9.61%	17.59%	5.7分
21	特宝生物	8.13%	10.52%	6.3分
22	金迪克	8.07%	22.30%	5.6分
23	神州细胞	7.59%	15.09%	5.3分
24	百奥泰	6.87%	15.96%	5.7分
25	康弘药业	6.69%	14.51%	6.0分
26	华兰疫苗	6.22%	7.76%	5.1分
27	康华生物	5.93%	10.19%	4.9分
28	-	5.58%	7.42%	分
29	东宝生物	5.49%	-1.70%	5.2分
30	安科生物	3.16%	8.80%	6.3分
31	通化东宝	3.13%	10.77%	6.0分
32	西藏药业	3.08%	8.93%	5.6分
33	康辰药业	1.93%	12.73%	6.4分
34	优宁维	1.40%	7.19%	5.1分
35	艾迪药业	1.28%	22.52%	5.7分
36	长春高新	1.26%	9.81%	6.1分
37	康希诺	1.18%	10.75%	6.0分
38	百克生物	0.95%	9.28%	4.9分
39	康泰生物	0.42%	7.93%	5.1分
40	辽宁成大	0.39%	3.19%	5.8分
41	华兰生物	0.00%	6.27%	5.1分
42	成大生物	-0.98%	6.17%	4.6分
43	近岸蛋白	-1.30%	14.73%	4.9分
44	智飞生物	-2.33%	6.94%	4.7分
45	万泽股份	-3.15%	16.82%	5.4分
46	博晖创新	-4.82%	8.61%	5.6分
47	四环生物	-4.95%	10.90%	6.6分
48	天坛生物	-5.43%	6.75%	5.5分
49	博雅生物	-7.17%	6.69%	5.6分
50	卫光生物	-8.92%	7.64%	5.2分
51	-	-9.22%	3.23%	分
52	上海莱士	-9.78%	6.96%	4.9分
53	*ST未名	-19.01%	7.81%	4.9分
54	派林生物	-27.65%	4.85%	4.9分

<上一页 1 2 3 4 5...9 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
海通证券	2012-09-11	增持	增持
山西证券	2012-09-11	增持	增持
国信证券	2012-09-11	买入	买入
长江证券	2012-09-11	增持	增持
长城证券	2012-09-10	买入	买入

基本面诊股

诊断结果：6.5基本面打败了71%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（60分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 3/71 ， 26/71。

[{"date":"2026-03-31","value":"4.67","vol":"-6.01"},{"date":"2025-12-31","value":"13.29","vol":"-12.99"},{"date":"2025-09-30","value":"11.61","vol":"-10.09"},{"date":"2025-06-30","value":"8.36","vol":"-0.66"},{"date":"2025-03-31","value":"5.10","vol":"-0.34"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	4.67	13.29	11.61	8.36	5.10
行业(%)	-6.01	-12.99	-10.09	-0.66	-0.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"71.11","vol":"61.43"},{"date":"2025-12-31","value":"71.75","vol":"66.53"},{"date":"2025-09-30","value":"73.61","vol":"67.71"},{"date":"2025-06-30","value":"73.07","vol":"66.67"},{"date":"2025-03-31","value":"75.49","vol":"38.38"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	71.11	71.75	73.61	73.07	75.49
行业(%)	61.43	66.53	67.71	66.67	38.38

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 26/71 ， 23/71。

[{"date":"2026-03-31","value":"7.39","vol":"297.05"},{"date":"2025-12-31","value":"19.62","vol":"39.85"},{"date":"2025-09-30","value":"21.00","vol":"45.81"},{"date":"2025-06-30","value":"24.40","vol":"6902.14"},{"date":"2025-03-31","value":"15.34","vol":"6125.11"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	7.39	19.62	21.00	24.40	15.34
行业(%)	297.05	39.85	45.81	6902.14	6125.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"6.58","vol":"74.22"},{"date":"2025-12-31","value":"2.22","vol":"33.79"},{"date":"2025-09-30","value":"22.45","vol":"45.67"},{"date":"2025-06-30","value":"21.84","vol":"5.21"},{"date":"2025-03-31","value":"10.52","vol":"-8.79"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	6.58	2.22	22.45	21.84	10.52
行业(%)	74.22	33.79	45.67	5.21	-8.79

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，两项指标的行业排名分别为 21/71 ， 23/71。

[{"date":"2026-03-31","value":"0.07","vol":"0.06"},{"date":"2025-12-31","value":"0.30","vol":"0.29"},{"date":"2025-09-30","value":"0.23","vol":"0.21"},{"date":"2025-06-30","value":"0.15","vol":"0.13"},{"date":"2025-03-31","value":"0.08","vol":"0.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.07	0.30	0.23	0.15	0.08
行业(次)	0.06	0.29	0.21	0.13	0.06

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.22","vol":"0.29"},{"date":"2025-12-31","value":"0.91","vol":"1.29"},{"date":"2025-09-30","value":"0.63","vol":"0.90"},{"date":"2025-06-30","value":"0.45","vol":"0.55"},{"date":"2025-03-31","value":"0.23","vol":"0.25"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	0.22	0.91	0.63	0.45	0.23
行业(次)	0.29	1.29	0.90	0.55	0.25

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"-7.45","vol":"-78.67"},{"date":"2025-12-31","value":"27.62","vol":"12.85"},{"date":"2025-09-30","value":"3.31","vol":"0.21"},{"date":"2025-06-30","value":"10.41","vol":"-1377.65"},{"date":"2025-03-31","value":"-7.17","vol":"-2083.82"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	-7.45	27.62	3.31	10.41	-7.17
行业	-78.67	12.85	0.21	-1377.65	-2083.82

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"3.55","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"5.07","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	3.55	-	5.07	-
行业	0.00	1.74	0.00	1.55	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 5/71 ， 3/71。

[{"date":"2026-03-31","value":"1.61","vol":"6.66"},{"date":"2025-12-31","value":"1.06","vol":"5.80"},{"date":"2025-09-30","value":"1.34","vol":"6.07"},{"date":"2025-06-30","value":"1.28","vol":"6.57"},{"date":"2025-03-31","value":"1.37","vol":"7.73"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	1.61	1.06	1.34	1.28	1.37
行业	6.66	5.80	6.07	6.57	7.73

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.18","vol":"5.14"},{"date":"2025-12-31","value":"0.66","vol":"4.43"},{"date":"2025-09-30","value":"0.82","vol":"4.89"},{"date":"2025-06-30","value":"0.78","vol":"5.24"},{"date":"2025-03-31","value":"0.88","vol":"6.33"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	1.18	0.66	0.82	0.78	0.88
行业	5.14	4.43	4.89	5.24	6.33

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：一般，低于行业平均，两项指标的行业排名分别为 10/71 ， 5/71。

[{"date":"2026-03-31","value":"64.38","vol":"28.78"},{"date":"2025-12-31","value":"61.47","vol":"28.75"},{"date":"2025-09-30","value":"60.01","vol":"28.02"},{"date":"2025-06-30","value":"59.38","vol":"26.19"},{"date":"2025-03-31","value":"58.89","vol":"26.65"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	64.38	61.47	60.01	59.38	58.89
行业(%)	28.78	28.75	28.02	26.19	26.65

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.02","vol":"2.54"},{"date":"2025-12-31","value":"1.76","vol":"1.42"},{"date":"2025-09-30","value":"1.67","vol":"0.58"},{"date":"2025-06-30","value":"1.64","vol":"1.11"},{"date":"2025-03-31","value":"1.61","vol":"0.80"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	2.02	1.76	1.67	1.64	1.61
行业(%)	2.54	1.42	0.58	1.11	0.80

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
长江证券	2026-06-28	买入
兴业证券	2026-04-30	增持
国盛证券	2026-04-28	买入
国海证券	2026-04-27	买入
华创证券	2026-04-21	增持

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"1.02","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.77","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.93","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.97","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"3.30","blueLineValue":"0.65","type":"YC"}]

[万泽股份]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]